These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1822436)

  • 1. The outer membrane permeability-increasing action of linear analogues of polymyxin B nonapeptide.
    Vaara M
    Drugs Exp Clin Res; 1991; 17(9):437-43. PubMed ID: 1822436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do salicylates and ascorbate increase the outer membrane permeability to hydrophobic antibiotics in Pseudomonas aeruginosa?
    Vaara M
    Drugs Exp Clin Res; 1990; 16(11):569-74. PubMed ID: 2129299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymyxin B octapeptide and polymyxin B heptapeptide are potent outer membrane permeability-increasing agents.
    Kimura Y; Matsunaga H; Vaara M
    J Antibiot (Tokyo); 1992 May; 45(5):742-9. PubMed ID: 1624376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the cell envelope in the antibacterial activities of polymyxin B and polymyxin B nonapeptide against Escherichia coli.
    Sahalan AZ; Dixon RA
    Int J Antimicrob Agents; 2008 Mar; 31(3):224-7. PubMed ID: 18083010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of the hydrophobic domain of polymyxin B nonapeptide: effect on outer-membrane permeabilization and lipopolysaccharide neutralization.
    Tsubery H; Ofek I; Cohen S; Eisenstein M; Fridkin M
    Mol Pharmacol; 2002 Nov; 62(5):1036-42. PubMed ID: 12391265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of polymyxin B nonapeptide on daptomycin permeability and cell surface properties in Pseudomonas aeruginosa, Escherichia coli, and Pasteurella multocida.
    Morris CM; George A; Wilson WW; Champlin FR
    J Antibiot (Tokyo); 1995 Jan; 48(1):67-72. PubMed ID: 7868392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-function studies of polymyxin B nonapeptide: implications to sensitization of gram-negative bacteria.
    Tsubery H; Ofek I; Cohen S; Fridkin M
    J Med Chem; 2000 Aug; 43(16):3085-92. PubMed ID: 10956216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The outer membrane permeability-increasing action of deacylpolymyxins.
    Viljanen P; Matsunaga H; Kimura Y; Vaara M
    J Antibiot (Tokyo); 1991 May; 44(5):517-23. PubMed ID: 1648055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An outer membrane-disorganizing peptide PMBN sensitizes E. coli strains to serum bactericidal action.
    Vaara M; Viljanen P; Vaara T; Mäkelä PH
    J Immunol; 1984 May; 132(5):2582-9. PubMed ID: 6325539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and membrane action of polymyxin B analogues.
    Clausell A; Rabanal F; Garcia-Subirats M; Asunción Alsina M; Cajal Y
    Luminescence; 2005; 20(3):117-23. PubMed ID: 15924313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationships of bacterial outer-membrane permeabilizers based on polymyxin B heptapeptides.
    Urakawa H; Yamada K; Komagoe K; Ando S; Oku H; Katsu T; Matsuo I
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1771-5. PubMed ID: 20138759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid binding and membrane penetration of polymyxin B derivatives studied in a biomimetic vesicle system.
    Katz M; Tsubery H; Kolusheva S; Shames A; Fridkin M; Jelinek R
    Biochem J; 2003 Oct; 375(Pt 2):405-13. PubMed ID: 12848621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymyxin B and polymyxin B nonapeptide alter cytoplasmic membrane permeability in Escherichia coli.
    Dixon RA; Chopra I
    J Antimicrob Chemother; 1986 Nov; 18(5):557-63. PubMed ID: 3027012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of polymyxin B nonapeptide on Aeromonas salmonicida.
    McCashion RN; Lynch WH
    Antimicrob Agents Chemother; 1987 Sep; 31(9):1414-9. PubMed ID: 2823698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of polymyxin B nonapeptide to gram-negative bacteria.
    Vaara M; Viljanen P
    Antimicrob Agents Chemother; 1985 Apr; 27(4):548-54. PubMed ID: 2988430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gram-negative outer and inner membrane models: insertion of cyclic cationic lipopeptides.
    Clausell A; Garcia-Subirats M; Pujol M; Busquets MA; Rabanal F; Cajal Y
    J Phys Chem B; 2007 Jan; 111(3):551-63. PubMed ID: 17228913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting lipopolysaccharides by the nontoxic polymyxin B nonapeptide sensitizes resistant Escherichia coli to the bactericidal effect of human neutrophils.
    Rose F; Heuer KU; Sibelius U; Hombach-Klonisch S; Kiss L; Seeger W; Grimminger F
    J Infect Dis; 2000 Jul; 182(1):191-9. PubMed ID: 10882597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neopeptide antibiotics that function as opsonins and membrane-permeabilizing agents for gram-negative bacteria.
    Tsubery H; Yaakov H; Cohen S; Giterman T; Matityahou A; Fridkin M; Ofek I
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3122-8. PubMed ID: 16048913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leakage of periplasmic proteins from Escherichia coli mediated by polymyxin B nonapeptide.
    Dixon RA; Chopra I
    Antimicrob Agents Chemother; 1986 May; 29(5):781-8. PubMed ID: 3015004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of polymyxin B nonapeptide (PMBN) on transformation.
    Viljanen P
    Biochem Biophys Res Commun; 1987 Mar; 143(3):923-7. PubMed ID: 3032189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.